Wessely, A.; Steeb, T.; Leiter, U.; Garbe, C.; Berking, C.; Heppt, M.V.
Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020? Int. J. Mol. Sci. 2020, 21, 9300.
https://doi.org/10.3390/ijms21239300
AMA Style
Wessely A, Steeb T, Leiter U, Garbe C, Berking C, Heppt MV.
Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020? International Journal of Molecular Sciences. 2020; 21(23):9300.
https://doi.org/10.3390/ijms21239300
Chicago/Turabian Style
Wessely, Anja, Theresa Steeb, Ulrike Leiter, Claus Garbe, Carola Berking, and Markus Vincent Heppt.
2020. "Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020?" International Journal of Molecular Sciences 21, no. 23: 9300.
https://doi.org/10.3390/ijms21239300
APA Style
Wessely, A., Steeb, T., Leiter, U., Garbe, C., Berking, C., & Heppt, M. V.
(2020). Immune Checkpoint Blockade in Advanced Cutaneous Squamous Cell Carcinoma: What Do We Currently Know in 2020? International Journal of Molecular Sciences, 21(23), 9300.
https://doi.org/10.3390/ijms21239300